Tirilazad

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Tirilazad
Tirilazad.png
Systematic (IUPAC) name
(16α)-21-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]-16-methylpregna-1,4,9(11)-triene-3,20-dione
Identifiers
CAS Number 110101-66-1 N
ATC code N07XX01 (WHO)
PubChem CID 104903
ChemSpider 94673 YesY
UNII YD064E883I YesY
KEGG D08606 YesY
ChEMBL CHEMBL1630578 N
Synonyms (8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
Chemical data
Formula C38H52N6O2
Molar mass 624.859 g/mol
 NYesY (what is this?)  (verify)

Tirilazad is a drug that has been proposed to treat acute ischaemic stroke. When tested on animal models, tirilazad protects brain tissue, and reduces brain damage. However, the drug fails to treat, and even worsens a stroke when studied on a human being.[1]

Usage in treatment of stroke[edit]

Tirilazad currently has no usage in the clinical treatment of stroke.

References[edit]

  1. ^ "Tirilazad for acute ischaemic stroke". Retrieved 2007-07-28.